The Board of Directors of PT Asuransi Jiwa Sinarmas MSIG Tbk (the 'Company') hereby informs the Shareholders that the Company has held the Annual General Meeting of Shareholders (the 'Meeting') on:

Day/Date

:

Tuesday, June 27, 2023

Time

:

14.20 – 14.59 WIB

Venue

:

Sinarmas Land Plaza, Tower II, Lantai 39

Jl. M.H. Thamrin No. 51, Jakarta Pusat

With the Meeting Agenda, as follows:

Approval of the Company’s Annual Report that has been reviewed by the Board of Commissioners, including the Supervisory Report of the Board of Commissioners and Financial Statements of the Company for the financial year ended on 31 December 2022.
Approval of the appropriation of the Company’s net profit for the financial year ended on 31 December 2022.
Approval of the delegation of authority to the Board of Commissioners on the proposal of the Nomination and Remuneration Committee of the Company regarding the determination of salary, allowance, tantiem, and/or bonuses to members of the Board of Directors and the Board of Commissioners of the Company for the financial year 2023.
Approval of the delegation of authority to the Company's Board of Commissioners to appoint a Public Accountant to examine the Company’s Financial Statements for the financial year 2023.
Approval on the Reappointment of the Board of Directors, Board of Commissioners, and Sharia Supervisory Board (as evaluated by Nomination and Remuneration Committee).

A. Member of Company’s management who attended the Meeting

President Director	:	Mr. Wianto
Director	:	Mr. Herman Sulistyo

Member of the Board of Directors, Board of Commissioners and Sharia Supervisory Board who participate through teleconference media:

Deputy President Director	:	Mr. Satoshi Shiratani
Director	:	Mr. Tomoyuki Monden
Independent Commissioner	:	Mr. Ardhayadi Mitroatmodjo
Chairman of Sharia Supervisory Board	:	Mr. Endy Muhammad Astiwara
Member of Sharia Supervisory Board	:	Mr. Ahmadi Sukarno

B. Quorum of the Shareholders Attendances

The Meeting was attended by 1,680,077,310 shareholders or proxy of shareholders with valid voting rights or equal to 80% of the total 2,100,000,000 shares with valid voting rights issued by the Company.

C. Opportunity to Raise Questions and/or Express Opinion Relating to the Meeting Agenda

Shareholders or their proxies who present at the Meeting were given opportunity to raise questions and/or to express opinion relating to each Meeting Agenda, however there was none of shareholders or their proxies at the Meeting who raised questions and/or express opinion for the Meeting Agenda.

D. Resolution Mechanism in the Meeting

The resolution was adopted through direct voting and electronic voting (e-voting).

E. Resolution Result in the Meeting

Resolution result for all Meeting Agendas were fully adopted by deliberation for consensus from all shareholders present or representing 1,680,077,310 shares (100% of the total valid shares and present at the Meeting).

F. Meeting Resolutions

All matters discussed and resolved in the Meeting were recorded in the Minutes of the Extraordinary General Meeting of Shareholders Deed No. 57 dated June 27, 2023 which was drawn up by Notary Aryanti Artisari, S.H., M.Kn with summary as follows:

First Meeting Agenda

Approved the Company's Annual Report and Board of Commissioners' Supervisory Report for the financial year ended on December 31, 2022.
Ratified the Company's Financial Statements for the financial year ended on December 31, 2022 which have been audited by the Public Accounting Firm of Purwantono, Sungkoro & Surja, a member of Ernst & Young Global in accordance with the Independent Auditor's Report No. 00558/2.1032/AU.1/08/0240-1/1/III/2023 dated March 31, 2022, with a reasonable opinion in all material respects in accordance with Financial Accounting Standards in Indonesia.
Granted full release and waiver from responsibility (acquit et de charge) to all members of the Board of Directors of the Company for management actions and to all members of the Board of Commissioners of the Company for supervisory actions that have been carried out during the financial year 2022, to the extent that these actions are reflected in the Company's Financial Statements for the financial year 2022.

Second Meeting Agenda

1. Determined that based on the Company's Financial Statements for the financial year ended on December 31, 2022, audited by Purwantono, Sungkoro & Surja Public Accountants (a member of Ernst & Young Global), the net profit of the Company for the financial year ended on December 31, 2022, amounts to IDR 367,773,000,000 (Three Hundred Sixty-Seven Billion Seven Hundred Seventy-Three Million Rupiah) ('2022 Net Profit;).

2. Approved the profit allocation as follows:

a. Allocated a certain amount of 4,500,000,000 (Four Billion Five Hundred Million Rupiah) from the remaining undistributed and undesignated 2022 Net Profit as an additional General Reserve of the Company.

b. A total of IDR 371,700,000,000 (Three Hundred Seventy-One Billion Seven Hundred Million Rupiah) (or at IDR 177 (One Hundred Seventy-Seven Rupiah) per share) originating from 2022 Net Profit and the accumulated remaining profit from the previous year will be distributed as cash dividends to the Shareholders. The amount of the cash dividend is equivalent to 101% of the 2022 Net Profit.

c. The payment of cash dividends is subject to the following terms and conditions:

Cash Dividend for year 2022 shall be paid for each share issued by the Company which is registered in Company’s Shareholders List on recording date, determined by the Board of Directors;
Upon payment of cash dividend for year 2022, Board of Directors are granted substitution right to do tax deduction in accordance with prevailing tax regulation;
Granting power with substitution right to the Company’s Board of Directors to determine any matters related to the payment of cash dividend for year 2022, including but not limited to set the schedule and procedure of cash dividend distribution by adhering to OJK regulation, IDX regulation and other related regulations, and accordingly to submit report and/or ask for approval to authorized parties, and perform all necessary actions in accordance with distribution of dividend in line with prevailing laws.

3. Schedule of Dividend Payment

No	Information	Date
1	Report of Cash Dividend Distribution to IDX	4 Juli 2023
2	Announcement of Cash Dividend Distribution	4 Juli 2023
3	Cum Dividend Date in Regular Market and Negotiated Market	10 Juli 2023
4	Ex Dividend Date in Regular Market and Negotiated Market	11 Juli 2023
5	Cum Dividend Date in Cash Market	12 Juli 2023
6	Ex Dividend Date in Cash Market	13 Juli 2023
7	Recording Date of Shareholders who are entitled on Cash Dividend	12 Juli 2023
8	Dividend Payment Date for Year 2022	28 Juli 2023

Third Meeting Agenda

Granted the authority to the Board of Commissioners based on the Nomination and Remuneration Committee’s proposal to determine salaries, benefits, tantiem, and/or bonuses to members of the Board of Directors of the Company for the financial year 2023 by considering the Company's financial condition.
Granted the authority to the Board of Commissioners based on the Nomination and Remuneration Committee's proposal to determine salaries or honorariums, allowances, tantiem, and/or bonuses for members of the Company's Board of Commissioners for the financial year 2023 while considering the Company's financial condition.

Fourth Meeting Agenda

Granted the authority to the Board of Commissioners to appoint an Independent Public Accountant from an Independent Public Accounting Firm registered with the Financial Services Authority to audit the Company's Financial Statements for the financial year ended on December 31, 2023, which is still ongoing, based on the following criteria: Public Accountants and Public Accounting Firms must be registered with the Financial Services Authority and must be independent and professional parties to audit the Company's financial statements for the financial year ended on December 31, 2023, by considering the Audit Committee's recommendations.
Granted the authority to the Board of Commissioners to determine the amount of honorarium and other requirements in connection with the appointment of the Public Accountant/Public Accounting Firm in line with applicable rules.

Fifth Meeting Agenda

1. Approved the reappointment of the members of the Board of Commissioners, Board of Directors, and Sharia Supervisory Board of the Company, effective from the Annual General Meeting of Shareholders (Annual GMS) in 2023 until the closure of the second (2nd) Annual GMS held in 2025, as follows:

Mr. Indra Widjaja as President Commissioner
Mr. Toshinari Tokoi as Commissioner
Mr. Hideaki Nomura as Commissioner
Mr. Ardhayadi Mitroatmodjo as Independent Commissioner
Mr. Sidharta Akmam as Independent Commissioner
Mr. Herman Sulistyo as Director
Mr. Andrew Bain as Director
Mr. Endy Muhammad Astiwara as Chairman of the Sharia Supervisory Board
Mr. Ahmadi Sukarno as a member of the Sharia Supervisory Board

2. Granted ratification and affirmation of all legal actions undertaken by Mr. Indra Widjaja, Mr. Toshinari Tokoi, Mr. Hideaki Nomura, Mr. Ardhayadi Mitroatmodjo, Mr. Sidharta Akmam, Mr. Herman Sulistyo, Mr. Andrew Bain, Mr. Endy Muhammad Astiwara, Mr. Ahmadi Sukarno, from the closing of the Annual General Meeting in 2021 until the closing of this Meeting.

3. Henceforth, the composition of member of the Company’s Board of Directors, Board of Commissioners, and Sharia Supervisory Board to be as follow:

BOARD OF DIRECTORS

President Director	:	Mr. Wianto
Deputy President Director	:	Mr. Satoshi Shiratani
Director	:	Mr. Herman Sulistyo
Director	:	Mr. Tomoyuki Monden
Director	:	Mr. Andrew Bain
Director	:	Mr. Ken Terada

BOARD OF COMMISSIONERS

President Commissioner	:	Mr. Indra Widjaja
Commissioner	:	Mr. Toshinari Tokoi
Commissioner	:	Mr. Hideaki Nomura
Independent Commissioner	:	Mr. Ardhayadi Mitroatmodjo
Independent Commissioner	:	Mr. Sidharta Akmam
Independent Commissioner	:	Ms. Nazly Parlindungan Siregar

SHARIA SUPERVISORY BOARD

Chairman	:	Mr. Endy Muhammad Astiwara
Member	:	Mr. Ahmadi Sukarno

4. Granted power with substitution right to the Company’s Board of Directors and/or Chief Compliance, Legal & Corporate Secretary to re-state the whole or part of this Meeting’s resolution into Notarial deed and notify such composition of the members of the Company’s management to the Ministry of Law and Human Rights of the Republic of Indonesia and other authorities, as well as to take all necessary actions in accordance with the prevailing regulations.

This summary of the minutes of Meeting is also available and can be accessed on the Company's website (www.msiglife.co.id).

Jakarta, June 30, 2023

PT Asuransi Jiwa Sinarmas MSIG Tbk

Company’s Board of Directors

Organization Structure